RPL9 and acute lymphoblastic leukemia: Our findings further suggest that RPL9 KD increases MICA/B mRNA and protein expression in B-ALL cells, which serves as crucial ligands of NK cell's NKG2D, potentially heightening their sensitivity to NK cell-mediated cytotoxicity.